Learn More
Genscript Corporation CD164 hFc Chimera Human
Supplier: Genscript Corporation Z04164500

CD164 was found to play a role in many malignant diseases CD164 was associated with clinical and pathological features of patients High level of CD164 was related to the distant metastasis and vascular invasion of bladder cancer patients CD164 was associated with the poor clinical outcomes of BC patients Silencing of CD164 could inhibit the progression of tumors in vivo and in vitro which may become an effective target in the treatment of bladder cancer
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.